Loading clinical trials...
Loading clinical trials...
African American (AA) women are more vulnerable to HIV infection than other women. Truvada, when used as pre-exposure prophylaxis (PrEP), is one of the most effective approaches for HIV prevention; however, PrEP use among AA women remains low and has not responded to traditional interventions. This study proposes for the first time an innovative computer-based motivational intervention, increasing PrEP uptake (iPrEP), which couples motivational messages woven into a traditional survey to raise awareness of risky sex and substance use behaviors.
Age
18 - 55 years
Sex
FEMALE
Healthy Volunteers
Yes
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Start Date
November 13, 2019
Primary Completion Date
December 31, 2021
Completion Date
December 31, 2021
Last Updated
August 18, 2022
40
ACTUAL participants
iPrEP
BEHAVIORAL
Usual Care
BEHAVIORAL
Lead Sponsor
The University of Texas Health Science Center, Houston
NCT04142047
NCT06694805
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07428330